Log in

NASDAQ:SRLS - SeraCare Life Sciences Stock Price, Forecast & News

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Today's Range N/A
50-Day Range N/A
52-Week Range N/A
VolumeN/A
Average VolumeN/A
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
BetaN/A
SeraCare Life Sciences, Inc. (SeraCare) serves the global life sciences industry by providing products and services to facilitate the discovery, development and production of human and animal diagnostics and therapeutics. The Company's portfolio includes diagnostic controls, plasma-derived reagents and molecular biomarkers, bio banking and contract research services. It operates two segments: Diagnostic and Biopharmaceutical Products, and BioServices. The Diagnostic & Biopharmaceutical Products segment includes two types of products: controls and panels. The Bio Services segment includes bio banking, sample processing and testing services for research and clinical trials, and contract research services in molecular biology, virology, immunology and biochemistry.

Industry, Sector and Symbol

Industry N/A
Sub-IndustryN/A
SectorN/A
Current SymbolNASDAQ:SRLS
CUSIPN/A
Phone+1-508-2446400

Debt

Price-To-Earnings

Sales & Book Value

Annual SalesN/A

Profitability

Miscellaneous

EmployeesN/A
Next Earnings DateN/A
OptionableNot Optionable

Receive SRLS News and Ratings via Email

Sign-up to receive the latest news and ratings for SRLS and its competitors with MarketBeat's FREE daily newsletter.


SeraCare Life Sciences (NASDAQ:SRLS) Frequently Asked Questions

What is SeraCare Life Sciences' stock symbol?

SeraCare Life Sciences trades on the NASDAQ under the ticker symbol "SRLS."

Has SeraCare Life Sciences been receiving favorable news coverage?

News coverage about SRLS stock has been trending extremely negative recently, InfoTrie Sentiment Analysis reports. The research firm identifies positive and negative media coverage by monitoring more than six thousand news and blog sources in real-time. The firm ranks coverage of public companies on a scale of -5 to 5, with scores nearest to five being the most favorable. SeraCare Life Sciences earned a media sentiment score of -4.5 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for SeraCare Life Sciences.

What is SeraCare Life Sciences' official website?

The official website for SeraCare Life Sciences is http://www.seracare.com/.

How can I contact SeraCare Life Sciences?

SeraCare Life Sciences' mailing address is 37 Birch St, MILFORD, MA 01757-5501, United States. The company can be reached via phone at +1-508-2446400.


MarketBeat Community Rating for SeraCare Life Sciences (NASDAQ SRLS)

Community Ranking:  2.2 out of 5 (star star)
Outperform Votes:  43 (Vote Outperform)
Underperform Votes:  56 (Vote Underperform)
Total Votes:  99
MarketBeat's community ratings are surveys of what our community members think about SeraCare Life Sciences and other stocks. Vote "Outperform" if you believe SRLS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe SRLS will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 1/26/2020 by MarketBeat.com Staff

Featured Article: What is a capital gain?

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel